Data presented at the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) suggests that daily use of the antiviral agent Valtrex(R) (valacyclovir HCl) in patients prone to cold sores may significantly reduce the chances of recurrent bouts of the disease.
Since Valtrex is in the news, Vidyya has the prescibing/product information for you in this issue. Valtrex is the hydrochloride salt of L-valyl ester of the antiviral drug acyclovir and is under investigation as oral suppressant therapy for oral cold sores. Currently the drug is indicated for the control of genital herpes and shingles.
At the same meeting, it was announced that Zyvox® (linezolid injection, tablets and for oral suspension) may assist some patients with certain difficult-to-treat infections to be discharged from hospitals sooner. Indications for Zyvox include the treatment of adults with complicated skin and skin structure infections caused by Staphylococcus aureus (methicillin-susceptible and resistant), Streptococcus agalactiae and Streptococcus pyogenes.
Zyvox and Valtrex are among many medications discussed at this week's meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Though we cannot secure the prescribing medications for all of the agents discussed at the meeting, we can follow the medications that are in the news and provide you with prescribing information where possible. You'll find information on Zyvox in this issue.
In unrelated, patient oriented news, the general public may be unaware that this time of year is the peak time for exposure to tick-borne illness. Patients should know that limiting exposure to ticks is the most effective way to reduce the likelihood of Rocky Mountain spotted fever (or any other tick-borne)infection. In persons exposed to tick-infested habitats, prompt careful inspection and removal of crawling or attached ticks is an important method of preventing disease as it may take several hours of attachment before organisms are transmitted from the tick to the host.
The articles in today's Vidyya are:
As always, we hope you enjoy the issue.